Schonfeld Strategic Advisors LLC Amylyx Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 21,600 shares of AMLX stock, worth $99,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,600Holding current value
$99,144% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
44.6MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$19.4 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$15.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$12.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$12 Million0.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA1.9MShares$8.74 Million1.57% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $269M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...